I agree that this site is using cookies. You can find further informations here.
X
Cheeseman, Sue
41  results:
Search for persons X
?
1

Assessment of bone-targeting agents use in patients with bo..:

Seesaghur, Anouchka ; Egger, Peter ; Warden, Joshua...
BMJ Open.  13 (2023)  5 - p. e069214 , 2023
Link: https://doi.org/10.1136/..
 
?
2

Ovarian Real-World International Consortium (ORWIC): A mult..:

Cheeseman, Sue ; Levick, Bethany ; Sopwith, Will...
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
3

Trends in the prescription of systemic anticancer therapy a..:

Snee, Michael ; Cheeseman, Sue ; Thompson, Matthew...
BMJ Open.  11 (2021)  5 - p. e043442 , 2021
Link: https://doi.org/10.1136/..
 
?
4

Treatment patterns and survival outcomes for patients with ..:

Snee, Michael ; Cheeseman, Sue ; Thompson, Matthew...
BMJ Open.  11 (2021)  9 - p. e046396 , 2021
Link: https://doi.org/10.1136/..
 
?
5

Systemic treatment of hormone receptor positive, human epid..:

Twelves, Chris ; Cheeseman, Sue ; Sopwith, Will...
BMC Cancer.  20 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
6

Current Treatment and Outcomes Benchmark for Locally Advanc..:

Cheeseman, Sue ; Thompson, Matthew ; Sopwith, Will...
Frontiers in Oncology.  10 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
7

Randomised, open-label, phase II study of gemcitabine with ..:

Dalgleish, Angus G ; Stebbing, Justin ; Adamson, Douglas JA...
British Journal of Cancer.  115 (2016)  7 - p. 789-796 , 2016
Link: https://doi.org/10.1038/..
 
?
8

Erratum: Randomised, open-label, phase II study of gemcitab..:

Dalgleish, Angus G ; Stebbing, Justin ; Adamson, Douglas J A...
British Journal of Cancer.  115 (2016)  9 - p. e16-e16 , 2016
Link: https://doi.org/10.1038/..
 
?
9

Assessment of bone-targeting agents use in patients with bo..:

Seesaghur, Anouchka ; Egger, Peter ; Warden, Joshua...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410833/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
10

Trends in the prescription of systemic anticancer therapy a..:

Snee, Michael ; Cheeseman, Sue ; Thompson, Matthew...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098989/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

Current Treatment and Outcomes Benchmark for Locally Advanc..:

Cheeseman, Sue ; Thompson, Matthew ; Sopwith, Will...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044411/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
12

Randomised, open-label, phase II study of gemcitabine with ..:

Dalgleish, Angus G ; Stebbing, Justin ; Adamson, Douglas JA...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046215/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
13

Table_1_Ovarian Real-World International Consortium (ORWIC)..:

Sue Cheeseman ; Bethany Levick ; Will Sopwith...
doi:10.3389/fonc.2023.1114435.s002.  , 2023
Link: https://doi.org/10.3389/..
 
?
14

Ovarian Real-World International Consortium (ORWIC): A mult..:

Sue Cheeseman ; Bethany Levick ; Will Sopwith...
https://www.frontiersin.org/articles/10.3389/fonc.2023.1114435/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
15

Assessment of bone-targeting agents use in patients with bo..:

Matthew Thompson ; Peter Egger ; Sue Cheeseman...
https://bmjopen.bmj.com/content/13/5/e069214.full.  , 2023
Link: https://doi.org/10.1136/..
 
1-15